PR News
The Mylan EpiPen Pricing Crisis: A Pharmaceutical Communications Case Study
The Mylan EpiPen pricing crisis of 2016 — from $100 in 2009 to $600+ in 2016, the congressional hearings, the defensive CNBC interview, the generic EpiPen response, the eventual Viatris merger. Four enduring lessons for pharmaceutical crisis communications.